Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nrx Pharmaceuticals Inc (NQ: NRXP )

0.7003 -0.0197 (-2.74%)
Streaming Delayed Price Updated: 3:58 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 107,876
Open 0.7100
Bid (Size) 0.7000 (1)
Ask (Size) 0.7350 (71)
Prev. Close 0.7200
Today's Range 0.6890 - 0.7200
52wk Range 0.4899 - 3.025
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
FDA Suggests NRx Pharma's Bipolar Program To Be Enlarged For Chronic Treatment Of Patients With Suicidality
 
Via Benzinga

Performance

YTD
-42.12%
-42.12%
1 Month
-35.75%
-35.75%
3 Month
-35.16%
-35.16%
6 Month
+7.74%
+7.74%
1 Year
-75.43%
-75.43%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Mawson Infrastructure, NRx Pharmaceuticals And This Penny Stock Insiders Are Aggressively Buying
Via Benzinga
Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
HC Wainwright Finds 'Synergies In Treatment' For This Bipolar-Focused Stock
Via Benzinga
FDA Turns Down NRx Pharmaceuticals' Emergency Use Submission For Covid-19 Candidate
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Relief Therapeutics, NRx Pharma Settle Litigation Regarding COVID-19 Treatment Candidate
Via Benzinga
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022
Via Benzinga
Earnings Scheduled For November 14, 2022
Via Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket
Via Benzinga
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
Via Benzinga
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
Via Benzinga
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022
Via Benzinga
What's Next For NRx Pharma As FDA Denies Breakthrough Therapy Tag For COVID-19 Therapy
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.